アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

nationwide laboratories, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 g in 100 ml - for dermatologic  use: salicylic acid 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked  and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and  psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic  acid 6% is a topical aid in the removal of excessive keratin on  dorsal and plantar hyperkeratotic  lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% should not be used in children under 2 years of age.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

nationwide laboratories, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 g in 100 g - for dermatologic  use: salicylic acid 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked  and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and  psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic  acid 6% is a topical aid in the removal of excessive keratin on  dorsal and plantar hyperkeratotic  lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% should not be used in children under 2 years of age.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

a-s medication solutions - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to w

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bryant ranch prepack - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions  (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis teratogenic effects: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malform

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bryant ranch prepack - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

a-s medication solutions - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions  (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis teratogenic effects: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malform

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

kroger co. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 19.8 mg in 1 g - acne medication for the treatment of acne

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

big lots - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 19.8 mg in 1 g - acne medication for the treatment of acne

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

wal-mart stores inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 19.8 mg in 1 g - acne medication for the treatment of acne

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

acella pharmaceuticals, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 60 mg in 1 g - indications and usage for the removal of excess keratin in hyperkeratotic disorders, including scaling associated with psoriasis or thickened skin of palms and soles, corns and calluses. contraindications salicylic acid 6% gel should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% gel should not be used in children under 2 years of age.